Compass Wealth Management »

Blueprint Medicines shares owned by Compass Wealth Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Compass Wealth Management from 13F filings

Historical chart of Compass Wealth Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Compass Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Compass Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $71k 750 94.86
2023-12-31 $69k 750 92.24

More positions owned by Compass Wealth Management

Broadcom (AVGO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
JPMorgan Chase & Co. (JPM)
Applied Materials (AMAT)
Constellation Brands Cl A (STZ)
Air Products & Chemicals (APD)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Energy Industries (AEIS)
Danaher Corporation (DHR)
Citigroup Com New (C)
Coty Com Cl A (COTY)
Alphabet Cap Stk Cl C (GOOG)
Blackstone Group Inc Com Cl A (BX)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)

View all positions for Compass Wealth Management

Top funds holding Blueprint Medicines

BlackRock
Vanguard Group
T. Rowe Price Associates
FMR
Wellington Management Company
Pictet Asset Management Holding SA
William Blair Investment Management
Geode Capital Management
Alliancebernstein
Lord, Abbett & Co
Jpmorgan Chase & Co
American Century Companies
Brown Advisory Holdings Incorporated
Susquehanna International
Avidity Partners Management

View all funds holding Blueprint Medicines